Bigger, better, sooner-scaling up for success

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 4, 2012, Pages 571-575

  Thun, Michael J ^a   Hoover, Robert N ^b   Hunter, David J ^c,d  

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; GESTAGEN;

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER RISK; GENETIC SUSCEPTIBILITY; HUMAN; MENOPAUSE; META ANALYSIS (TOPIC); OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859374330     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0191     Document Type: Review

References (36)

1. Defares JG. Is cancer preventable? Lancet 1971;1:135-6.
2. Hormone replacement therapy and cancer: is there cause for concern? Lancet 1989;2:368.
3. Steinberg KK, Thacker SB, Smith J, Stroup DF, Zack MM, Flanders WD, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.
4. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
5. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989;321:293-7. (Pubitemid 19193804)
6. Persson I, Weiderpass E, Bergkvist L, Bergström R, Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement therapy. Cancer Causes Control 1999;10:253-60. (Pubitemid 29358958)
7. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33. (Pubitemid 34761611)
8. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SLA, et al. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol 2008;167:1207-16. (Pubitemid 351670642)
9. Beral V, Reeves G, Bull DGreen J for the Million Women Study Collaborators. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 2011;103:296-305.
10. Chlebowski RT, Anderson GL. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment. J Natl Cancer Inst 2011;103:284-5.
11. Rous P. The influence of diet on transplanted and spontaneous tumors. J Exp Med 1914;20:433-51.
12. Tannenbaum A. Relationship of body weight to cancer incidence. Arch Pathol 1940;30:509-17.
13. Directors of the Actuarial Society of America and Association of Life Insurance. Medico-actuarial mortality investigation. New York: Spectator Company; 1913.
14. Dublin L. Some aspects of cancer mortality. Proc Am Life Insur Med Directors of America 1929;15:402.
15. Society of Actuaries. Build and blood pressure study. Chicago; 1959.
16. Wynder EL, Escher GC, Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer 1966;19:489-520.
17. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-76. (Pubitemid 9256615)
18. Armstrong BK, McMichael AJ, MacLennan R. Diet. In:Schottenfeld D, Fraumeni JP, editors. Cancer epidemiology and prevention, 1st ed. Philidelphia, PA: W.B. Saunders Company; 1982.
19. Willett W. Diet and nutrition. In:Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention, 2nd ed. New York, NY: Oxford University Press Inc.; 1996.
20. Fraumeni JF, DeVesa S, McLaughlin JK, Stanford JL. Biliary tract cancer. In:Schottenfeld D, Fraumeni J, editors. Cancer epidemiology and prevention, 1st ed. Philidelphia, PA: W.B. Saunders Company; 1982.
21. IARC. IARC handbooks of cancer prevention. Weight control and physical activity. Lyon: International Agency for Research on Cancer; 2002.
22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
23. Ballard-Barbash R, Friedenreich C, Slattery M, Thune I. Obesity and body composition. In:Schottenfeld D, Fraumeni J, editors. Cancer epidemiology and prevention, 3rd ed. New York, New York, Oxford University Press Inc.; 2006.
24. World Cancer Research Fund & American Institute for Cancer Research. Body composition, growth, and development. In: food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
25. Kitahara CM, Platz EA, Beane-Freeman LE, Hsing AW, Linet MS, Park Y. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 2011;20:464-72.
26. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61. (Pubitemid 44698579)
27. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48. (Pubitemid 24325685)
28. Hunter DJ, Thomas G, Hoover RN, Chanock SJ. Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? Cancer Causes Control 2007;18:479-84. (Pubitemid 46684818)
29. Hunter DJ, Chanock SJ. Genome-wide association studies and "the art of the soluble". J Natl Cancer Inst 2010;102:836-7.
30. Chung CC, Chanock SJ. Current status of genome-wide association studies in cancer. Hum Genet 2011;130:59-78.
31. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010;362:986-93.
32. Beckmann L, Hüsing A, Setiawan VW, Amiano P, Clavel-Chapelon F, Chanock SJ, et al. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolismin pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab 2011;96:e360-7.
33. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006;163:1053-64. (Pubitemid 43987598)
34. Hoover RN. The evolution of epidemiologic research from cottage industry to "big" science. Epidemiology 2007;18:13-7. (Pubitemid 46005902)
35. Ness RB. "Big" science and the little guy. Epidemiology 2007;18:9-12.
36. Graunt J. Natural and political observations made upon the bills of mortality. Wilcox WF editor. Baltimore, MD. The John Hopkins Press, 1939.